Kazia Therapeutics (KZIA) Assets (2009 - 2025)

Kazia Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $46.7 million for Q4 2025.

• Quarterly Assets rose 298.6% year-over-year to $46.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.7 million (up 298.6% YoY) and the FY2025 annual result came in at $3.9 million, down 72.72% from the prior year.
• Assets was $46.7 million for Q4 2025 at Kazia Therapeutics, up from $3.9 million in the prior quarter.
• Across five years, Assets topped out at $46.7 million in Q4 2025 and bottomed at $3.9 million in Q2 2025.
• A 5-year average of $23.1 million and a median of $18.5 million in 2022 frame the typical range for Assets.
• Peak annual rise in Assets reached 298.6% in 2025, while the deepest fall reached 72.72% in 2025.
• Kazia Therapeutics' Assets stood at $32.5 million in 2021, then slumped by 43.8% to $18.3 million in 2022, then declined by 13.21% to $15.9 million in 2023, then fell by 26.21% to $11.7 million in 2024, then jumped by 298.6% to $46.7 million in 2025.
• Business Quant data shows KZIA's Assets at $46.7 million in Q4 2025, $3.9 million in Q2 2025, and $11.7 million in Q4 2024.